![Scott Bizily](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 85 394 $ in data 30/06/2026
Scott P.
Bizily is Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. since 2024.
Dr. Bizily was General Counsel at Synthego Corp.
from 2019 to 2021.
Dr. Bizily was Director-Corporate Counsel at BioMarin Pharmaceutical, Inc. Dr. Bizily worked at Princeton University from 1991 to 1994.
Dr. Bizily earned a doctorate from the University of Georgia in 2001 and a graduate degree from the University of Pennsylvania in 2005.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2026 | 8.617 ( 0,02% ) | 114 606 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Responsabile della Conformità | 01/12/2021 |
| Società | Posizione | Fine |
|---|---|---|
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Consigliere Generale | 01/09/2021 |
| BIOMARIN PHARMACEUTICAL INC. | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
